Core Viewpoint - The Schwab US Dividend Equity ETF (SCHD) has experienced a significant decline, reaching its lowest level since February 4, 2026, with a drop of 4.40% from its peak this year, but it may rebound in the future [1][8]. Market Performance - SCHD has mirrored the performance of other American stock indices, particularly following the onset of the US-Iran war, but is better positioned to withstand the ongoing crisis compared to the S&P 500 and Nasdaq 100 [2]. Sector Analysis - The energy sector constitutes 20% of SCHD, including companies like ConocoPhillips, Chevron, and EOG Resources, which have performed well due to rising crude oil and natural gas prices [3]. - The healthcare segment accounts for approximately 16.3% of the fund, featuring companies such as Bristol Myers Squibb, Merck, Amgen, and AbbVie, which are also less affected by the Iran war [4]. - The technology sector has a minimal presence in SCHD, which is under scrutiny due to concerns about a potential AI bubble [5]. Federal Reserve Impact - The SCHD ETF's decline is partly attributed to fears of a more hawkish Federal Reserve stance amid rising inflation, with expectations of at least two interest rate hikes this year [6]. - Historically, SCHD tends to outperform the broader market during periods of interest rate hikes due to its composition of value stocks [7]. Valuation Metrics - SCHD is considered relatively undervalued, with a price-to-earnings (PE) ratio of 19, lower than the S&P 500 average of 23, and a price-to-cash-flow ratio of 10, also below the broader market [9]. Technical Analysis - The ETF has seen a decline from a record high of $31.95 to $30.60, with the Relative Strength Index (RSI) dropping from 86 to 40, indicating a shift from overbought to oversold conditions [10]. - The stock is expected to remain under pressure but may rebound, potentially reaching a 23.6% retracement level at $29.85 before resuming an upward trend [11].

Core Insights - The article discusses the performance of defensive sectors such as Utilities, Consumer Staples, and Health Care amidst current market volatility, suggesting that these sectors may indicate broader market risks [1][4]. Sector Analysis Utilities - The Utilities sector (XLU) is currently in a strong uptrend, characterized by a series of higher highs and higher lows since September 2023, with the long-term 200-day moving average rising [5][6]. - The relative strength of Utilities compared to the S&P 500 (SPY) shows a favorable trend, indicating increased investor demand for defensive positions [7]. Consumer Staples - The Consumer Staples sector (XLP) is approaching critical support levels around $84, with significant volume expected to enter at this price point [8]. - The price action for XLP is less clear compared to Utilities, with a potential consolidation pattern forming, suggesting that it may hold support and rally against the S&P 500 in the near future [9]. Health Care - The Health Care sector (XLV) is facing challenges, showing a bearish double top at $160, with recent price action indicating weakness [10][11]. - The sector's relative performance against the S&P 500 has been uninspiring, with sideways movement since December, suggesting a lack of momentum [12]. Market Context - The article emphasizes the importance of monitoring sector strength as a gauge for broader market risk, particularly as the S&P 500 struggles [4][18]. - Defensive sectors can still experience rallies even in a volatile market, and their analysis should be part of a broader investment strategy [14][15].

Economic Overview - The U.S. economy experienced a job loss of 92,000 in February, significantly worse than the estimated loss of 50,000 and below the revised January total of 126,000, marking the third decline in five months [1] Unemployment Rates - The unemployment rate increased to 4.4%, with a broader measure of unemployment, including discouraged workers and part-time workers for economic reasons, decreasing to 7.9%, which is 0.2 percentage points lower than January [2] Sector Performance - The health care sector, which has been a primary growth driver, lost 28,000 jobs due to a strike at Kaiser Permanente that affected over 30,000 workers in Hawaii and California [3] - The information services sector lost 11,000 jobs, continuing a trend of an average loss of 5,000 jobs per month over the past year due to cuts related to artificial intelligence [3] - Federal government employment decreased by 10,000 jobs, with a total decline of 330,000 jobs, or 11% of the total workforce, since October 2024 [4] - The transportation and warehousing sector also saw a reduction of 11,000 jobs, while social assistance was one of the few sectors to gain, adding 9,000 jobs [4]

Core Insights - The ALPS Sector Dividend Dogs ETF (SDOG) is experiencing a market rotation away from technology stocks towards sectors perceived as less vulnerable to artificial intelligence disruption [1] - The fund has returned 10.45% year-to-date and 3.94% over the past month, indicating strong performance amid sector-level shifts [1] - Significant gains were observed in utilities and basic materials, with Edison International (EIX) rising 20% and LyondellBasell Industries (LYB) increasing by 17.4% in February [1] Sector Performance - The Morningstar U.S. Energy Index surged 24.97%, the Basic Materials Index rose 18.73%, and the Industrials Index climbed 16.99%, while the Technology Index declined by 5.41% [1] - Software stocks are under pressure, with many falling 30% to 40% this year due to fears of AI disruption, exemplified by Accenture (ACN) declining 20.8% [1] Fund Methodology - SDOG's strategy involves selecting the five highest-yielding stocks from each of the 10 market sectors, allowing it to capture investor preferences across sectors [1] - The fund charges a 0.36% expense ratio and pays quarterly distributions, maintaining roughly 10% allocations across all sectors as of December 31 [1] Notable Stock Performances - Dow Inc. (DOW) gained 11.5% and Altria Group Inc. (MO) added 11.4% in February, reflecting the fund's focus on high-dividend, established companies [1] - Health care stocks like Bristol-Myers Squibb Co. (BMY) and Merck & Co. Inc. (MRK) also performed well, rising 13.3% and 12.3% respectively, avoiding the turbulence faced by technology stocks [1]

Group 1 - The article does not provide any relevant content regarding the company or industry [1]

Core Insights - Revvity, Inc. (RVTY) has a market capitalization of $11.4 billion and operates in the global health sciences sector, providing advanced instruments, reagents, software, and services for diagnostics, genomics, drug discovery, and life sciences research [1] Stock Performance - Over the past 52 weeks, RVTY shares have declined by 12.5%, underperforming the S&P 500 Index, which has gained nearly 13%. However, on a year-to-date basis, RVTY shares have increased by 3.7%, outperforming the S&P 500's marginal return [2] - RVTY shares have also lagged behind the State Street Health Care Select Sector SPDR ETF (XLV), which has seen a 6.5% increase over the same period [3] Financial Performance - Revvity reported Q4 2025 results with revenue of $772 million and adjusted EPS of $1.70, driven by strong growth in Diagnostics, which saw fourth-quarter revenue of $390 million, reflecting a 10% reported growth and 7% organic growth. The company has provided optimistic guidance for full-year 2026, forecasting revenue between $2.96 billion and $2.99 billion, with 2% to 3% organic growth and adjusted EPS of $5.35 to $5.45 [6] - For the fiscal year ending December 2026, analysts expect RVTY's adjusted EPS to grow by 6.9% year-over-year to $5.41. The company has a strong earnings surprise history, having exceeded consensus estimates in the last four quarters [7] Analyst Ratings - Among 18 analysts covering RVTY, the consensus rating is a "Moderate Buy," consisting of eight "Strong Buy" ratings, one "Moderate Buy," and nine "Holds" [7] - Baird analyst Catherine Ramsey Schulte raised the price target on Revvity to $129 while maintaining an "Outperform" rating. The mean price target of $119.40 indicates a 19% premium to RVTY's current price levels, while the highest price target of $140 suggests a potential upside of 39.5% [8]

The demand for help navigating the famously complex US health care system has propelled a startup called Solace Health to a $1 billion valuation https://t.co/YOd7DJLOQj ...

Core Insights - The U.S. job market is expected to show an addition of 55,000 jobs in January, an increase from 50,000 in December, with a focus on health care employment [1][9] - The unemployment rate is projected to remain steady at 4.4%, which is considered low historically [2][9] Job Market Dynamics - Job gains are anticipated to be primarily in the health care sector, while opportunities in other fields are becoming scarcer due to a prevailing no-hiring mindset among employers [2] - The Federal Reserve is increasingly concerned about a potential rise in unemployment, as job openings in December were at their lowest since 2020, indicating a possible slowdown in job growth [3] Economic Implications - The upcoming report is crucial for assessing whether the job market is deteriorating and if a recent hiring slowdown is leading to significant job losses [4] - A revision of past job data is expected to reveal nearly a million fewer jobs added between March 2024 and March 2025 than previously reported, indicating a grim outlook for the job market [5][6] External Influences - Recent government policies, including tariffs and immigration restrictions, have contributed to uncertainty in the job market, affecting hiring and expansion plans [8][9] - The increasing use of AI technology is also leading some companies to reduce their workforce, further complicating the employment landscape [8]

Job Cuts Overview - U.S.-based employers announced 71,321 job cuts in November 2025, marking a 24% increase from the previous year and the highest for November since 2022 [1][2] - January 2026 saw a significant rise in job cuts, with 108,435 announced, representing a 118% increase from under 50,000 in January 2025 and a 205% increase from 35,553 in December 2025 [4] Industry-Specific Job Cuts - The transportation industry accounted for 31,243 job cuts, primarily due to UPS's announcement of 30,000 layoffs following its split with Amazon [7] - The technology sector reported 22,291 job cuts, largely attributed to Amazon's plan to lay off 16,000 employees, with indications that over-hiring rather than AI technology is driving these reductions [7] - The health care industry announced 17,107 job cuts, the worst month since April 2020, influenced by inflation, high labor costs, and lower reimbursements from Medicaid and Medicare [8] - Chemical manufacturers reported over 4,700 job cuts, with Dow Inc. contributing significantly, marking the highest monthly total since February 2016 [8] Economic Outlook - The high number of job cuts in January suggests that employers are pessimistic about the economic outlook for 2026, with many plans likely set at the end of 2025 [3]

Group 1 - The Challenger report indicates a total of 108,435 job cuts announced in January, marking the highest January total since 2009 [1] - Job cuts in January are up 205% from December, with only 5,306 employers announcing hiring plans, the lowest January total since 2009 [1] - The transportation sector experienced the most significant job cuts, primarily due to UPS announcing 30,000 job cuts, followed by Amazon with 16,000 [2] Group 2 - Health care also saw substantial job cuts, which is unusual for this sector [3] - It is important to note that the Challenger report reflects job cut announcements rather than actual cuts, and some announced cuts may not be executed [3] - Future jobless claims and payroll numbers will provide further insights into the actual impact of these announcements [3]